Trial Profile
Phase II Trial of Temodal 4 Hourly in Progressive Breast Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2016
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 16 Oct 2005 New trial record.